Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs-Reference-Cited by-同舟云学术

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs

Published:2013-03-12 Issue:3 Volume:12 Page:299-307
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Garg Vishvas,Raisch Dennis W,McKoy June M,Trifilio Steven M,Holbrook Jamiee,Edwards Beatrice J,Belknap Steven M,Samaras Athena T,Nardone Beatrice,West Dennis P

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2013.780024

Reference32 articles.

1. Incidence of Adverse Drug Reactions in Hospitalized Patients

2. Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

3. Systematic Review of the Incidence and Characteristics of Preventable Adverse Drug Events in Ambulatory Care

4. The Gray Areas of Black Box Warnings

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Bisabolol, a Dietary Sesquiterpene, Attenuates Doxorubicin-Induced Acute Cardiotoxicity in Rats by Inhibiting Cellular Signaling Pathways, Nrf2/Keap-1/HO-1, Akt/mTOR/GSK-3β, NF-κB/p38/MAPK, and NLRP3 Inflammasomes Regulating Oxidative Stress and Inflammatory Cascades;International Journal of Molecular Sciences;2023-09-13

2. Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials;Journal of Oncology Pharmacy Practice;2020-07-19

3. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin;Biochemical and Biophysical Research Communications;2019-09

4. Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations;British Journal of Clinical Pharmacology;2017-12-20

5. Melphalan hydrochloride for the treatment of multiple myeloma;Expert Opinion on Pharmacotherapy;2017-07-10